Seeing Is Believing
Currently out of the existing stock ratings of Nathan Weinstein, 51 are a BUY (98.08%), 1 are a HOLD (1.92%).
Analyst Nathan Weinstein, carries an average stock price target met ratio of 37.12% that have a potential upside of 48.72% achieved within 285 days. Previously, Nathan Weinstein worked at AEGIS.
Nathan Weinstein’s has documented 93 price targets and ratings displayed on 22 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ATAI, ATAI Life Sciences BV at 02-Jul-2025.
Analyst best performing recommendations are on AMRN (AMARIN PLC).
The best stock recommendation documented was for AMRN (AMARIN PLC) at 10/31/2019. The price target of $460 was fulfilled within 15 days with a profit of $131.6 (40.07%) receiving and performance score of 26.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Mar-2026
$8
$0.65 (8.84%)
$12
1 months 19 days ago
(12-Aug-2026)
0/2 (0%)
$0.77 (10.65%)
Buy Since 19-Oct-2021
$7.5
$0.15 (2.04%)
$25
2 months 11 days ago
(20-Jul-2026)
0/14 (0%)
$0.31 (4.31%)
Buy Since 01-Sep-2021
$7.5
$0.15 (2.04%)
2 months 14 days ago
(17-Jul-2026)
1/4 (25%)
$0.28 (3.88%)
406
Buy Since 15-Feb-2026
$16
2 months 14 days ago
(17-Jul-2026)
0/3 (0%)
$11.97 (297.02%)
Buy Since 13-Jul-2021
$8
$0.65 (8.84%)
$17
2 months 15 days ago
(16-Jul-2026)
0/11 (0%)
$0.85 (11.89%)